CBIZ (NYSE:CBZ) is scheduled to post its quarterly earnings results before the market opens on Thursday, April 25th. Analysts expect CBIZ to post earnings of $0.68 per share for the quarter. CBIZ has set its FY 2019 guidance at $1.20-1.22 EPS and its FY19 guidance at $1.20-1.22 EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.

CBIZ (NYSE:CBZ) last posted its earnings results on Wednesday, February 13th. The business services provider reported ($0.02) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.04) by $0.02. The company had revenue of $199.00 million for the quarter, compared to analyst estimates of $202.33 million. CBIZ had a net margin of 6.68% and a return on equity of 10.45%. The business’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same period last year, the business posted $0.04 earnings per share. On average, analysts expect CBIZ to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

CBZ opened at $20.62 on Wednesday. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $1.14 billion, a price-to-earnings ratio of 18.92 and a beta of 0.50. CBIZ has a twelve month low of $18.30 and a twelve month high of $24.38.

In related news, Director Joseph S. Dimartino sold 3,488 shares of the firm’s stock in a transaction on Friday, March 1st. The shares were sold at an average price of $20.63, for a total transaction of $71,957.44. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Todd J. Slotkin sold 3,500 shares of the firm’s stock in a transaction on Friday, March 15th. The stock was sold at an average price of $20.14, for a total transaction of $70,490.00. Following the sale, the director now owns 40,375 shares in the company, valued at $813,152.50. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 35,442 shares of company stock worth $737,163. 7.40% of the stock is currently owned by company insiders.

Several equities research analysts have weighed in on the stock. Zacks Investment Research upgraded shares of CBIZ from a “sell” rating to a “hold” rating in a report on Tuesday, January 1st. ValuEngine lowered shares of CBIZ from a “buy” rating to a “hold” rating in a report on Tuesday, March 12th.

WARNING: “CBIZ (CBZ) Scheduled to Post Earnings on Thursday” was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States & international copyright & trademark laws. The original version of this piece can be accessed at https://www.watchlistnews.com/cbiz-cbz-scheduled-to-post-earnings-on-thursday/2983705.html.

About CBIZ

CBIZ, Inc provides professional business services, products, and solutions that help its clients in managing finances and employees. It offers its services through three groups: Financial Services, Benefits and Insurance Services, and National Practices. The Financial Services group provides accounting and tax, government healthcare consulting, financial advisory, valuation, and risk and advisory services.

Featured Article: Understanding debt-to-equity ratio in fundamental analysis

Earnings History for CBIZ (NYSE:CBZ)

Receive News & Ratings for CBIZ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBIZ and related companies with MarketBeat.com's FREE daily email newsletter.